(Total Views: 529)
Posted On: 05/28/2025 5:36:14 PM
Post# of 153896
another link from stocktwits:
https://www.curetoday.com/view/leronlimab-lin...ast-cancer
Key Takeaways
Leronlimab increases PD-L1 expression on circulating tumor cells, potentially converting "cold" tumors to "hot" ones, enhancing immune response in metastatic triple-negative breast cancer.
In a study, 88% of patients receiving leronlimab showed increased PD-L1 levels, suggesting improved responsiveness to immune checkpoint inhibitors
https://www.curetoday.com/view/leronlimab-lin...ast-cancer
Key Takeaways
Leronlimab increases PD-L1 expression on circulating tumor cells, potentially converting "cold" tumors to "hot" ones, enhancing immune response in metastatic triple-negative breast cancer.
In a study, 88% of patients receiving leronlimab showed increased PD-L1 levels, suggesting improved responsiveness to immune checkpoint inhibitors
(3)
(0)
